Delivery Order SPE2DB20D1100-SPE2DB25FA6P8

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,670.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and firm fixed-price instrument for the supply of VRAYLAR 1.5 MG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,376.89 firm fixed-price delivery order is for VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,597.55 firm fixed-price delivery order contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $12,955.49 with a Firm Fixed Price pricing type and an ultimate completion date of March 4, 2024. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,986.56 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication, to support military healthcare programs. The contract has a completion date of June 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,928.57, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 14, 2023. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,227.83 firm fixed-price delivery order is for the supply of VRAYLAR 4.5 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,458.98, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type, and has an ultimate completion date of December 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,666.16 delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,083.88, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA6P8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $12,312.68 with a firm fixed price. It is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/16/25, 12:37 PM